Bionime Corp (4737) - Total Liabilities

Latest as of September 2025: NT$3.73 Billion TWD ≈ $117.44 Million USD

Based on the latest financial reports, Bionime Corp (4737) has total liabilities worth NT$3.73 Billion TWD (≈ $117.44 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 4737 cash flow conversion to assess how effectively this company generates cash.

Bionime Corp - Total Liabilities Trend (2009–2024)

This chart illustrates how Bionime Corp's total liabilities have evolved over time, based on quarterly financial data. Check 4737 financial resilience to evaluate the company's liquid asset resilience ratio.

Bionime Corp Competitors by Total Liabilities

The table below lists competitors of Bionime Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Solstice Minerals Ltd AU:SLS	Australia	AU$835.60K
Mineralbrunnen Überkingen-Teinach GmbH & Co. KGaA F:MUT	Germany	€69.33 Million
First Capital Inc NASDAQ:FCAP	USA	$1.10 Billion
Stratus Properties Inc NASDAQ:STRS	USA	$240.48 Million
Barton Gold Holdings Ltd AU:BGD	Australia	AU$14.80 Million
Golden Long Teng Development Co Ltd TWO:3188	Taiwan	NT$7.06 Billion
Suheung Capsul KO:008490	Korea	₩500.48 Billion

Liability Composition Analysis (2009–2024)

This chart breaks down Bionime Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 4737 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.75	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.67	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bionime Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bionime Corp (2009–2024)

The table below shows the annual total liabilities of Bionime Corp from 2009 to 2024.

Year	Total Liabilities	Change
2024-12-31	NT$3.89 Billion ≈ $122.63 Million	+17.68%
2023-12-31	NT$3.31 Billion ≈ $104.20 Million	+13.95%
2022-12-31	NT$2.90 Billion ≈ $91.45 Million	+16.67%
2021-12-31	NT$2.49 Billion ≈ $78.38 Million	+3.05%
2020-12-31	NT$2.41 Billion ≈ $76.06 Million	+2.41%
2019-12-31	NT$2.36 Billion ≈ $74.27 Million	-9.20%
2018-12-31	NT$2.60 Billion ≈ $81.80 Million	+13.01%
2017-12-31	NT$2.30 Billion ≈ $72.38 Million	+11.54%
2016-12-31	NT$2.06 Billion ≈ $64.89 Million	+1.70%
2015-12-31	NT$2.03 Billion ≈ $63.81 Million	-38.99%
2014-12-31	NT$3.32 Billion ≈ $104.60 Million	-3.87%
2013-12-31	NT$3.45 Billion ≈ $108.81 Million	+31.25%
2012-12-31	NT$2.63 Billion ≈ $82.90 Million	+49.00%
2011-12-31	NT$1.77 Billion ≈ $55.64 Million	+552.49%
2010-12-31	NT$270.64 Million ≈ $8.53 Million	+7.74%
2009-12-31	NT$251.19 Million ≈ $7.91 Million	--

About Bionime Corp

TW:4737 Taiwan Medical Instruments & Supplies

Market Cap

$151.21 Million

NT$4.80 Billion TWD

Market Cap Rank

#17610 Global

#900 in Taiwan

Share Price

NT$62.10

Change (1 day)

-0.96%

52-Week Range

NT$51.50 - NT$80.00

All Time High

NT$91.20